Structure-Activity Relationship Study of N6-Benzoyladenine-Type BRD4 Inhibitors and Their Effects on Cell Differentiation and TNF-α Production

被引：10

作者：

Amemiya, Seika ^{[1
]}

Yamaguchi, Takao ^{[1
]}

Sakai, Taki ^{[1
]}

Hashimoto, Yuichi ^{[1
]}

Noguchi-Yachide, Tomomi ^{[1
]}

机构：

[1] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan

来源：

CHEMICAL & PHARMACEUTICAL BULLETIN | 2016年 / 64卷 / 09期

关键词：

bromodomain; bromodomain and extra-terminal domain (BET); BRD4; cell differentiation; tumor necrosis factor (TNF)-alpha; BROMODOMAIN PROTEIN BRD4; NF-KAPPA-B; P-TEFB; C-MYC; LEUKEMIA; RECOGNITION; THALIDOMIDE; RELEASE; TARGET;

D O I：

10.1248/cpb.c16-00410

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Bromodomains are epigenetic 'readers' of histone acetylation. The first potent bromodomain and extra terminal domain (BET) inhibitors, (+)-JQ1 and I-BET762 (also known as GSK525762), were reported in 2010. Some BET inhibitors are already under clinical trial for the treatment of cancers, but so far, only a few chemical scaffolds are available. We have reported potent N-6-benzoyladenine-based inhibitors of BRD4, a BET family member that serves as a key mediator of transcriptional elongation. Here we present an analysis of the structure activity relationships of these inhibitors. Among the compounds examined, 20, 28 and 29 enhanced all-trans retinoic acid (ATRA)-induced HL-60 cell differentiation and inhibited tumor necrosis factor (TNF)-alpha production by THP-1 cells.

引用

页码：1378 / 1383

页数：6

共 25 条

[1] BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc [J].

Delmore, Jake E. ;

Issa, Ghayas C. ;

Lemieux, Madeleine E. ;

Rahl, Peter B. ;

Shi, Junwei ;

Jacobs, Hannah M. ;

Kastritis, Efstathios ;

Gilpatrick, Timothy ;

Paranal, Ronald M. ;

Qi, Jun ;

Chesi, Marta ;

Schinzel, Anna C. ;

McKeown, Michael R. ;

Heffernan, Timothy P. ;

Vakoc, Christopher R. ;

Bergsagel, P. Leif ;

Ghobrial, Irene M. ;

Richardson, Paul G. ;

Young, Richard A. ;

Hahn, William C. ;

Anderson, Kenneth C. ;

Kung, Andrew L. ;

Bradner, James E. ;

Mitsiades, Constantine S. .

CELL, 2011, 146 (06) :903-916

[2] The double bromodomain protein Brd4 binds to acetylated chromatin during interphase and mitosis [J].

Dey, A ;

Chitsaz, F ;

Abbasi, A ;

Misteli, T ;

Ozato, K .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (15) :8758-8763

[3] Histone Recognition and Large-Scale Structural Analysis of the Human Bromodomain Family [J].

Filippakopoulos, Panagis ;

Picaud, Sarah ;

Mangos, Maria ;

Keates, Tracy ;

Lambert, Jean-Philippe ;

Barsyte-Lovejoy, Dalia ;

Felletar, Ildiko ;

Volkmer, Rudolf ;

Mueller, Susanne ;

Pawson, Tony ;

Gingras, Anne-Claude ;

Arrowsmith, Cheryl H. ;

Knapp, Stefan .

CELL, 2012, 149 (01) :214-231

[4] Selective inhibition of BET bromodomains [J].

Filippakopoulos, Panagis ;

Qi, Jun ;

Picaud, Sarah ;

Shen, Yao ;

Smith, William B. ;

Fedorov, Oleg ;

Morse, Elizabeth M. ;

Keates, Tracey ;

Hickman, Tyler T. ;

Felletar, Ildiko ;

Philpott, Martin ;

Munro, Shonagh ;

McKeown, Michael R. ;

Wang, Yuchuan ;

Christie, Amanda L. ;

West, Nathan ;

Cameron, Michael J. ;

Schwartz, Brian ;

Heightman, Tom D. ;

La Thangue, Nicholas ;

French, Christopher A. ;

Wiest, Olaf ;

Kung, Andrew L. ;

Knapp, Stefan ;

Bradner, James E. .

NATURE, 2010, 468 (7327) :1067-1073

[5] Structural development of biological response modifiers based on thalidomide [J].

Hashimoto, Y .

BIOORGANIC & MEDICINAL CHEMISTRY, 2002, 10 (03) :461-479

[6] Brd4 Coactivates Transcriptional Activation of NF-κB via Specific Binding to Acetylated RelA [J].

Huang, Bo ;

Yang, Xiao-Dong ;

Zhou, Ming-Ming ;

Ozato, Keiko ;

Chen, Lin-Feng .

MOLECULAR AND CELLULAR BIOLOGY, 2009, 29 (05) :1375-1387

[7] The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription [J].

Jang, MK ;

Mochizuki, K ;

Zhou, MS ;

Jeong, HS ;

Brady, JN ;

Ozato, K .

MOLECULAR CELL, 2005, 19 (04) :523-534

[8] RETINOBENZOIC ACIDS .1. STRUCTURE-ACTIVITY-RELATIONSHIPS OF AROMATIC AMIDES WITH RETINOIDAL ACTIVITY [J].

KAGECHIKA, H ;

KAWACHI, E ;

HASHIMOTO, Y ;

HIMI, T ;

SHUDO, K .

JOURNAL OF MEDICINAL CHEMISTRY, 1988, 31 (11) :2182-2192

[9]

KOMORI A, 1993, CANCER RES, V53, P3462

[10]

KOMORI A, 1993, CANCER RES, V53, P1982

← 1 2 3 →